2016
2016
MSD
MSD
Innovation
Innovation
AR & VR
AR & VR
2016
MSD
Innovation
AR & VR
Use an innovative way to explain the mode of action of KEYTRUDA to HCPs.
CONTEXT / DEMAND
In 2016, MSD launched KEYTRUDA, a new immunotherapy indicated in advanced melanoma. KEYTRUDA works with the patient’s immune system to help fight certain cancers.
Objectives for MSD :
- Demonstrate the superiority of the drug
- Increase the participation and the impact of Professional Events with Oncologists
- Help HCPs explain to their patients how the treatment affects the melanoma
For Patients:
- Understand their pathology and the way their treatment works in their bodies.
CONTEXT / DEMAND
In 2016, MSD launched KEYTRUDA, a new immunotherapy indicated in advanced melanoma. KEYTRUDA works with the patient’s immune system to help fight certain cancers.
Objectives for MSD :
• Demonstrate the superiority of the drug
• Increase the participation and the impact of Professional Events with Oncologists
• Help HCPs explain to their patients how the treatment affects the melanoma
For Patients:
• Understand their pathology and the way their treatment works in their bodies.
SOLUTION
We created a Virtual Reality experience based on the Oculus Rift technology. Through this immersive experience, HCPs are enrolled in a journey within the human body, through the blood system to finally reach the tumor and understand the way the drug interferes with the melanoma. HCPs discovered this cutting-edge technology attending MSD Professional Events. They were impressed !
SOLUTION
We created a Virtual Reality experience based on the Oculus Rift technology. Through this immersive experience, HCPs are enrolled in a journey within the human body, through the blood system to finally reach the tumor and understand the way the drug interferes with the melanoma. HCPs discovered this cutting-edge technology attending MSD Professional Events. They were impressed !
